Wilms tumor protein-1-derived 9-mer peptide induces CD4 T-cell responses in an HLA-DR restricted manner

被引：0

作者：

Fuji, S. ^{[1
]}

Fischer, J. ^{[2
]}

Kapp, M. ^{[1
]}

Stevanovic, S. ^{[3
]}

Bumm, T. ^{[1
]}

Rammensee, H. G. ^{[3
]}

Einsele, H. ^{[1
]}

Huenig, T. ^{[2
]}

Grigoleit, G. U. ^{[1
]}

机构：

[1] Poliklin II, Wurzburg, Germany

[2] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany

[3] Inst Cell Biol, Tubingen, Germany

来源：

BONE MARROW TRANSPLANTATION | 2013年 / 48卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S159 / S159

页数：1

共 50 条

[1] Wilms Tumor Protein-1-Derived 9-Mer Peptide Induces CD4 T-Cell Responses in an HLA-DR Restricted Manner
Fuji, Shigeo
Fischer, Julia
Kapp, Markus
Bumm, Thomas G.
Einsele, Hermann
Stevanovic, Stefan
Rammensee, Hans-Georg
Hunig, Thomas
Grigoleit, Goetz Ulrich
BLOOD, 2012, 120 (21)
[2] Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Xiao, Jianmei
Wan, Xing
Wang, Haoliang
Deng, Guohong
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (176):
[3] Vaccinia-specific CD4 T-cell responses in humans are predominantly restricted by HLA DR
Jing, Lichen
McCaughey, Stella Mayo
Davies, D. Huw
Chong, Tiana M.
Felgner, Phillip L.
Kwok, William W.
Wilson, Christopher B.
Koelle, David M.
JOURNAL OF IMMUNOLOGY, 2009, 182
[4] Identification of a Wilms' tumor 1-derived immunogenic CD4+ T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes
Anguille, S.
Fujiki, F.
Smits, E. L.
Oji, Y.
Lion, E.
Oka, Y.
Berneman, Z. N.
Sugiyama, H.
LEUKEMIA, 2013, 27 (03) : 748 - 750
[5] Identification of a Wilms’ tumor 1-derived immunogenic CD4+ T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes
S Anguille
F Fujiki
E L Smits
Y Oji
E Lion
Y Oka
Z N Berneman
H Sugiyama
Leukemia, 2013, 27 : 748 - 750
[6] FUNCTIONAL INTERACTION BETWEEN HUMAN T-CELL PROTEIN CD4 AND THE MAJOR HISTOCOMPATIBILITY COMPLEX HLA-DR ANTIGEN
GAY, D
MADDON, P
SEKALY, R
TALLE, MA
GODFREY, M
LONG, E
GOLDSTEIN, G
CHESS, L
AXEL, R
KAPPLER, J
MARRACK, P
NATURE, 1987, 328 (6131) : 626 - 629
[7] The Polyomavirus BK Large T-Antigen-Derived Peptide Elicits an HLA-DR Promiscuous and Polyfunctional CD4+ T-Cell Response
Ramaswami, Bala
Popescu, Iulia
Macedo, Camila
Luo, Chunqing
Shapiro, Ron
Metes, Diana
Chalasani, Geetha
Randhawa, Parmjeet S.
CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (05) : 815 - 824
[8] Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion
Gascon, RL
Narváez, AB
Zhang, RZ
Kahn, JO
Hecht, FM
Herndier, BG
McGrath, MS
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 30 (02) : 146 - 153
[9] The ADAMTS131239-1253 peptide is a dominant HLA-DR1-restricted CD4+ T-cell epitope
Gilardin, Laurent
Delignat, Sandrine
Peyron, Ivan
Ing, Mathieu
Lone, Yu-Chun
Gangadharan, Bagirath
Michard, Baptiste
Kherabi, Yousra
Sharma, Meenu
Pashov, Anastas
Latouche, Jean-Baptiste
Hamieh, Mohamad
Toutirais, Olivier
Loiseau, Pascale
Galicier, Lionel
Veyradier, Agnes
Kaveri, Srini
Maillere, Bernard
Coppo, Paul
Lacroix-Desmazes, Sebastien
HAEMATOLOGICA, 2017, 102 (11) : 1833 - 1841
[10] A synthetic peptide mimicking the HLA-DR beta 2-binding site for CD4 inhibits antigen-independent CD4(+) T cell adhesion to B cells and CD4(+) T cell activation
Mazerolles, F
Barbat, C
Fischer, A
INTERNATIONAL IMMUNOLOGY, 1996, 8 (02) : 267 - 274

← 1 2 3 4 5 →